Skip to main content

Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma.

Federico A, Steinfass T, Larribere L, Novak D, Moris F, Nunez LE, Umansky V, Utikal J
Mol Ther Oncolytics. 2020 Jun 4;18:83-99. doi: 10.1016/j.omto.2020.06.001. eCollection 2020 Sep 25. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.

Antibodies from Article